BiotechTube
Home/Eliksa Therapeutics/Armen Karamanian, MD, PhD
AK

Armen Karamanian, MD, PhD

Co-Founder & CEO

Eliksa Therapeutics

Therapeutic Areas

Rare DiseasesOphthalmologyDermatology

Eliksa Therapeutics Pipeline

DrugIndicationPhase
ELK-003Ocular manifestations of Epidermolysis Bullosa (EB)Pre-clinical/Early Clinical

Leadership Team at Eliksa Therapeutics

JH
Jane Hollingsworth
Co-Founder & Executive Chairman
GV
Garrett Vygantas, MD
Board Member
View full Eliksa Therapeutics profile